Hemostats
SKU
MRR-961BA04A2E36
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 3.23 billion
2030
USD 4.75 billion
2024
USD 3.42 billion
CAGR
5.65%

Hemostats Market by Type (Collagen-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats), Formulation (Matrix & Gel Hemostats, Powder Hemostats, Sheet & Pad Hemostats), Application - Global Forecast 2024-2030

[196 Pages Report] The Hemostats Market size was estimated at USD 3.23 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 5.65% to reach USD 4.75 billion by 2030.

Hemostats Market
To learn more about this report, request a free PDF copy

The hemostats are a range of medical devices and products designed to control, prevent, and stop bleeding during surgical procedures and traumatic injuries. These devices play an important role in managing blood loss and facilitate proper tissue healing while reducing the risk of complications. Hemostats have applications in numerous surgical specialties, including cardiovascular surgery, general surgery, orthopedic surgery, neurosurgery, gynecologic surgery, and dental surgery. The growing occurrence of chronic diseases among an aging population drives the demand for surgeries that necessitate effective blood loss management solutions, consequently expanding the utilization of diverse hemostatic agents. Additionally, increasing inclination toward minimally invasive procedures with rising investments by government bodies and healthcare organizations to improve surgical infrastructure is raising the usage of hemostats. High R&D costs associated with developing breakthrough products and a high risk of contamination with hemostats hamper market growth. The increasing development of biologically compatible hemostats by market vendors that minimize adverse effects while providing effective bleeding control is expected to create opportunities for market growth.

Hemostats Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding

Collagen-based hemostats are derived from purified collagen; they are known for their excellent biocompatibility and ability to accelerate clot formation by initiating platelet aggregation. These hemostats are often preferred in surgeries involving soft tissues and delicate structures, such as neurosurgery and ophthalmic surgery. Combination hemostats consist of two or more active agents that work synergistically to enhance hemostatic efficacy. They typically combine the benefits of hemostats, such as collagen-based, gelatin-based, and thrombin-based products. The demand for combination hemostats is growing due to their increased effectiveness in minimizing bleeding complications during complex surgical procedures. Oxidized regenerated cellulose-based hemostats are made from plant-derived cellulose that undergoes oxidation and regeneration processes. They possess antimicrobial properties and effectively control bleeding by creating a physical barrier between blood vessels and surrounding tissues. ORC-based hemostats are often used in dental surgeries, gastrointestinal surgeries, and gynecological procedures. Thrombin-based hemostats contain human or bovine thrombin as their active ingredient, which activates the coagulation cascade, resulting in rapid clot formation. They are particularly useful in controlling bleeding where traditional techniques may be ineffective or impractical, such as cardiovascular surgeries or organ transplantations. The collagen-based hemostats provide excellent biocompatibility and are often preferred for delicate surgeries. Combination hemostats offer increased effectiveness due to their synergistic properties. Gelatin-based hemostats are valued for their rapid blood clotting ability in critical situations. ORC-based hemostats exhibit antimicrobial properties and create a physical barrier for bleeding control, while thrombin-based hemostats activate the coagulation cascade for rapid clot formation.

Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention

Matrix and gel hemostats are biocompatible, absorbable materials that facilitate rapid clot formation. They are preferred in situations where the application of direct pressure during surgery is difficult, such as in minimally invasive procedures. Powder hemostats work by absorbing fluid from bleeding tissue and enhancing platelet aggregation. Their ease of application makes them suitable for various surgical specialties, including general, orthopedic, cardiovascular, and neurosurgery. Sheet and pad hemostats are flexible bioabsorbable materials, allowing for better conformity to irregular wound surfaces. They are utilized in surgeries where larger areas need to be covered, and suturing is challenging. Sponge hemostats are highly absorbent materials easily molded into various shapes, making them suitable for irregular wound cavities. They are commonly used in dental and oral surgeries, as well as neurosurgery and cardiovascular surgery. Matrix & gel hemostats provide rapid clot formation in hard-to-reach areas, whereas powder hemostats offer easy application across surgical specialties. Sheet & pad hemostats conform to irregular wound surfaces covering larger areas; then, sponge hemostats provide excellent absorbency and moldability for irregular wound cavities.

Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes

Cardiovascular surgeries involve high blood flow, arteries, and veins, often requiring efficient hemostatic solutions to prevent excessive bleeding. Hemostats are widely preferred in these procedures due to their rapid action and ability to achieve effective hemostasis. In general surgery, the use of hemostats plays a significant role in wound management and ensuring minimum blood loss during procedures such as appendectomy and hernia repair. Gynecological surgeries often require meticulous control of bleeding during delicate procedures such as hysterectomy and myomectomy. Hemostats have effectively minimized adhesions while providing adequate hemostasis during these surgeries. Hemostats are specifically designed to address this need while preserving neural structures. Orthopedic surgeries, including joint replacements and fracture fixation, require robust hemostatic agents as they involve cutting through dense bone and connective tissues. In reconstructive surgery, which includes skin grafting and flap reconstruction, managing blood loss becomes critical for successful outcomes. Hemostatic agents are preferred in these cases due to their adaptability across different tissues and ability to seal large wounds effectively. Compared to other applications, cardiovascular surgeries show a higher need-based preference for advanced hemostatic agents.

Regional Insights

The growing number of surgical procedures with the rising availability of advanced healthcare facilities, especially across the U.S., Canada, and Brazil, are expanding the growth of the hemostats market in the Americas. According to the American Society of Plastic Surgeons, in 2022, a total of 1,017,003 reconstructive surgeries were performed, necessitating the use of hemostats. The emerging trend of medical tourism across Canada, Dubai, Singapore, Japan, and the UK is expanding the number of minimally invasive surgical procedures, thereby creating a platform for the hemostats market. According to the Medical Tourism Index survey (MTA), Canada is one of the preferred destinations, attracting around 14 million Americans from other nations. Ongoing advancements in healthcare infrastructure and technologies across European countries, with constant support from regulatory bodies such as the European Medicines Agency (EMA) on expanding the manufacturing of medical devices and healthcare infrastructure, are bolstering the European market. The Middle East & Africa region presents promising growth opportunities due to increasing healthcare expenditure and government initiatives towards modernizing healthcare infrastructure. Countries, including Saudi Arabia, the United Arab Emirates, and South Africa, are witnessing a surge in the need for effective hemostatic solutions with the rising number of surgical interventions. Moreover, increased government funding to expand the manufacturing of medical devices domestically across India, Australia, China, and Japan and increased awareness associated with minimally invasive surgeries are expected to bolster market growth in Asia-Pacific.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hemostats Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hemostats Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures

    Teleflex Incorporated received clearance from the U.S. Food and Drug Administration (FDA) for the QuikClot Control+ Hemostatic Device. This device is now approved for use in cardiac surgical procedures to address mild and moderate bleeding, as well as bone surface bleeding after a sternotomy. [Published On: 2023-08-01]

  • Baxter Launches PERCLOT Absorbable Hemostatic Powder

    Baxter International Inc. introduced PERCLOT Absorbable Hemostatic Powder in the U.S., a passive hemostatic powder designed for patients with intact coagulation. PERCLOT's granules effectively absorb water, forming a gelled adhesive matrix that acts as a mechanical barrier against further bleeding. This process promotes the accumulation of platelets, red blood cells, and coagulation proteins, aiding in the hemostatic process. [Published On: 2023-07-24]

  • Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter

    Artivion, Inc. has received FDA premarket application approval for its absorbable hemostatic system, PerClot. In July 2021, Baxter acquired full ownership of PerClot through a sale agreement. The FDA approval of PerClot, Artivion represents a significant step ahead in optimizing patient care by addressing intraoperative bleeding. [Published On: 2023-05-24]

Key Company Profiles

The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Collagen-Based Hemostats
    • Combination Hemostats
    • Gelatin-Based Hemostats
    • Oxidized Regenerated Cellulose-Based Hemostats
    • Thrombin-Based Hemostats
  • Formulation
    • Matrix & Gel Hemostats
    • Powder Hemostats
    • Sheet & Pad Hemostats
    • Sponge Hemostats
  • Application
    • Cardiovascular Surgery
    • General Surgery
    • Gynecological Surgery
    • Neurological Surgery
    • Orthopedic Surgery
    • Reconstructive Surgery

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Hemostats Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hemostats Market?
  3. What are the technology trends and regulatory frameworks in the Hemostats Market?
  4. What is the market share of the leading vendors in the Hemostats Market?
  5. Which modes and strategic moves are suitable for entering the Hemostats Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Prevalence of chronic disorders with increasing need for surgical interventions
        2. Growing inclination toward minimally invasive surgeries
      2. Restraints
        1. Rising incidences of product recalls
      3. Opportunities
        1. Rise of biopolymer-based disposable hemostats
        2. Integration of nanotechnology to create more efficient and targeted hemostats
      4. Challenges
        1. Risk of infection and cross contamination associated with the use of hemostats tools and reagents
    2. Market Segmentation Analysis
      1. Type: Expanding the use of combination hemostats owing to their enhanced effectiveness in minimizing bleeding
      2. Formulation: Growing potential of powder hemostats for controlling and preventing bleeding during surgical intervention
      3. Application: Significant role of hemostats in cardiovascular surgeries to prevent blood loss and ensure successful outcomes
    3. Market Trend Analysis
      1. Robust and improving healthcare infrastructure and availability of improved hemostats in the Americas region
      2. Acceleration of medical tourism and expanding healthcare infrastructure with growing investment by the government in the Asia-Pacific
      3. Increase in number of medical tourists coupled with strong foothold of major healthcare companies in the EMEA region
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Hemostats Market, by Type
    1. Introduction
    2. Collagen-Based Hemostats
    3. Combination Hemostats
    4. Gelatin-Based Hemostats
    5. Oxidized Regenerated Cellulose-Based Hemostats
    6. Thrombin-Based Hemostats
  7. Hemostats Market, by Formulation
    1. Introduction
    2. Matrix & Gel Hemostats
    3. Powder Hemostats
    4. Sheet & Pad Hemostats
    5. Sponge Hemostats
  8. Hemostats Market, by Application
    1. Introduction
    2. Cardiovascular Surgery
    3. General Surgery
    4. Gynecological Surgery
    5. Neurological Surgery
    6. Orthopedic Surgery
    7. Reconstructive Surgery
  9. Americas Hemostats Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  10. Asia-Pacific Hemostats Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  11. Europe, Middle East & Africa Hemostats Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  12. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
      1. Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
      2. Baxter Launches PERCLOT Absorbable Hemostatic Powder
      3. Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
      4. Olympus Europa SE & Co. KG Expands Endoclot Partnership with Endoclot to Launch Hemostatic Agents
      5. Darling Ingredients Completes Acquisition of Brazilian Gelatin and Collagen Producer Gelnex
      6. Chitosan-Based Hemostat For Controlling Severe Surgical Bleeding Gets FDA Clearance
      7. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
      8. Medcura, Inc. Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
      9. Medtronic plc Nexpowder Endoscopic Hemostasis System Receives U.S. FDA Clearance
      10. Hemostasis LLC Closes Acquisition of Fiagon Medical Technologies
  13. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  14. List of Figures [Total: 22]
    1. HEMOSTATS MARKET RESEARCH PROCESS
    2. HEMOSTATS MARKET SIZE, 2023 VS 2030
    3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. HEMOSTATS MARKET DYNAMICS
    7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    8. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
    10. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    12. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    13. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    14. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    15. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    16. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    17. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    18. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
    22. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023
  15. List of Tables [Total: 298]
    1. HEMOSTATS MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL HEMOSTATS MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL HEMOSTATS MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL HEMOSTATS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    8. GLOBAL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    9. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL HEMOSTATS MARKET SIZE, BY COLLAGEN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL HEMOSTATS MARKET SIZE, BY COMBINATION HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
    14. GLOBAL HEMOSTATS MARKET SIZE, BY GELATIN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
    15. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL HEMOSTATS MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL HEMOSTATS MARKET SIZE, BY THROMBIN-BASED HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    20. GLOBAL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    21. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
    22. GLOBAL HEMOSTATS MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
    23. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL HEMOSTATS MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL HEMOSTATS MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL HEMOSTATS MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    30. GLOBAL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    31. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2023 (USD MILLION)
    32. GLOBAL HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2024-2030 (USD MILLION)
    33. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
    34. GLOBAL HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
    35. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
    36. GLOBAL HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
    37. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
    38. GLOBAL HEMOSTATS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
    39. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
    40. GLOBAL HEMOSTATS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
    41. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2023 (USD MILLION)
    42. GLOBAL HEMOSTATS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2024-2030 (USD MILLION)
    43. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    44. AMERICAS HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    45. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    46. AMERICAS HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    47. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    48. AMERICAS HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    49. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    50. AMERICAS HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    51. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    52. ARGENTINA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    53. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    54. ARGENTINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    55. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    56. ARGENTINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    57. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    58. BRAZIL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    59. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    60. BRAZIL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    61. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    62. BRAZIL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    63. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    64. CANADA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    65. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    66. CANADA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    67. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    68. CANADA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    69. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    70. MEXICO HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    71. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    72. MEXICO HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    73. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    74. MEXICO HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    75. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    76. UNITED STATES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    77. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    78. UNITED STATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    79. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    80. UNITED STATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    81. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    82. UNITED STATES HEMOSTATS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    83. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    84. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    85. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    86. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    87. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    88. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    89. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    90. ASIA-PACIFIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    91. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    92. AUSTRALIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    93. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    94. AUSTRALIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    95. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    96. AUSTRALIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    97. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    98. CHINA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    99. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    100. CHINA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    101. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    102. CHINA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    103. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    104. INDIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    105. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    106. INDIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    107. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    108. INDIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    109. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    110. INDONESIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    111. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    112. INDONESIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    113. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    114. INDONESIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    115. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    116. JAPAN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    117. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    118. JAPAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    119. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    120. JAPAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    121. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    122. MALAYSIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    123. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    124. MALAYSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    125. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    126. MALAYSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    127. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    128. PHILIPPINES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    129. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    130. PHILIPPINES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    131. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    132. PHILIPPINES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    133. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    134. SINGAPORE HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    135. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    136. SINGAPORE HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    137. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    138. SINGAPORE HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    139. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    140. SOUTH KOREA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    141. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    142. SOUTH KOREA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    143. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    144. SOUTH KOREA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    145. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    146. TAIWAN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    147. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    148. TAIWAN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    149. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    150. TAIWAN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    151. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    152. THAILAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    153. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    154. THAILAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    155. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    156. THAILAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    157. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    158. VIETNAM HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    159. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    160. VIETNAM HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    161. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    162. VIETNAM HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    163. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    164. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    165. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    166. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    167. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    168. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    169. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    170. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    171. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    172. DENMARK HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    173. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    174. DENMARK HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    175. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    176. DENMARK HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    177. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    178. EGYPT HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    179. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    180. EGYPT HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    181. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    182. EGYPT HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    183. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    184. FINLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    185. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    186. FINLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    187. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    188. FINLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    189. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    190. FRANCE HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    191. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    192. FRANCE HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    193. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    194. FRANCE HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    195. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    196. GERMANY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    197. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    198. GERMANY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    199. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    200. GERMANY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    201. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    202. ISRAEL HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    203. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    204. ISRAEL HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    205. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    206. ISRAEL HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    207. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    208. ITALY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    209. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    210. ITALY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    211. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    212. ITALY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    213. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    214. NETHERLANDS HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    215. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    216. NETHERLANDS HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    217. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    218. NETHERLANDS HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    219. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    220. NIGERIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    221. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    222. NIGERIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    223. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    224. NIGERIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    225. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    226. NORWAY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    227. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    228. NORWAY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    229. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    230. NORWAY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    231. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    232. POLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    233. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    234. POLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    235. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    236. POLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    237. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    238. QATAR HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    239. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    240. QATAR HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    241. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    242. QATAR HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    243. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    244. RUSSIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    245. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    246. RUSSIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    247. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    248. RUSSIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    249. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    250. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    251. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    252. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    253. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    254. SAUDI ARABIA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    255. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    256. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    257. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    258. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    259. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    260. SOUTH AFRICA HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    261. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    262. SPAIN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    263. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    264. SPAIN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    265. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    266. SPAIN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    267. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    268. SWEDEN HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    269. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    270. SWEDEN HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    271. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    272. SWEDEN HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    273. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    274. SWITZERLAND HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    275. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    276. SWITZERLAND HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    277. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    278. SWITZERLAND HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    279. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    280. TURKEY HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    281. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    282. TURKEY HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    283. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    284. TURKEY HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    285. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    286. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    287. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    288. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    289. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    290. UNITED ARAB EMIRATES HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    291. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    292. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    293. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
    294. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
    295. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    296. UNITED KINGDOM HEMOSTATS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    297. HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
    298. HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Companies Mentioned [Total: 40]
    1. A.R. Medicom, Inc.
    2. ACTEON Group
    3. Advamedica Inc.
    4. Advanced Medical Solutions Group PLC
    5. Advin Health Care
    6. Aegis Lifesciences Private Limited
    7. Argon Medical Devices
    8. B. Braun SE
    9. Baxter International Inc.
    10. Becton, Dickinson and Company
    11. Betatech Medical
    12. Convatec Group PLC
    13. Cook Group Incorporated
    14. Cortis Medtech Pvt Ltd
    15. Cotran Corporation
    16. Dolphin Sutures by Futura Surgicare Pvt. Ltd.
    17. Dynarex Corporation
    18. Gelita AG
    19. Hangzhou Singclean Medical Products Co.,Ltd.
    20. Healthium Medtech Ltd
    21. Hemostasis, LLC
    22. Integra LifeSciences Holdings Corporation
    23. Johnson & Johnson Services, Inc.
    24. Medcura, Inc.
    25. Medline Industries, LP
    26. Medprin Biotech GmbH
    27. Medtronic PLC
    28. Meril Life Sciences Pvt. Ltd.
    29. Olympus Corporation
    30. Pfizer Inc.
    31. Rousselot BV by Darling Ingredients International Holding B.V.
    32. Royal DSM
    33. Shilpa Medicare Limited
    34. Stapleline Medizintechnik GmbH
    35. Stryker Corporation
    36. SYMATESE
    37. Teleflex Incorporated
    38. Terumo Corporation
    39. Zhejiang Perfectseal New Material Technology Co., Ltd.
    40. Zimmer Biomet Holdings, Inc.
Hemostats: The Key to Successful Minimally Invasive Surgeries
July 3, 2023
BLOG
Hemostats: The Key to Successful Minimally Invasive Surgeries
In today's ever-evolving healthcare industry, the demand for minimally invasive surgeries (MIS) continues to grow steadily. MIS has replaced traditional open surgeries due to benefits such as shorter hospital stays, faster recovery time, and fewer complications. However, MIS has unique challenges, which can pose patient risks. One of the critical aspects of MIS is achieving hemostasis, or the ability to stop bleeding effectively. This is where Hemostats come in handy and prove to be an indispensable tool. This blog delve into the world of Hemostats and their role in successful minimally invasive surgeries.

Hemostats are medical devices that assist in controlling bleeding during surgical procedures. They are designed to be used as a primary means of achieving hemostasis or as an adjunct to other techniques. Hemostats interact with blood coagulation factors to form a clot, halting bleeding at the surgical site. Hemostats come in different types, including mechanical, absorbable, and topical Hemostats. The choice of Hemostat depends on various factors, including the surgical procedure, the patient's coagulation status, and the surgeon's preference.

In minimally invasive surgeries, using Hemostats becomes even more crucial because the surgical site is often challenging to visualize, access, and control. Hemostats help surgeons achieve quick hemostasis, reduce the risk of bleeding complications, and allow for a more efficient surgical procedure. Furthermore, Hemostats can also reduce the overall surgery costs by shortening the overall length of surgical time in cases of unexpected bleeding.

Mechanical Hemostats, or Hemostatic Clips, are the most commonly used Hemostats in minimally invasive surgeries. These Hemostats are applied at the bleeding site using a delivery device inserted through a small incision site. Hemostatic clips provide quick and efficient hemostasis, and their application is straightforward in most surgeries. Additionally, Hemostatic clips can be applied at a distance from the bleeding site, making them ideal for managing bleeding from a small-diameter vessel.

Topical Hemostats are absorbable or non-absorbable agents designed to control bleeding by forming a blood clot. These Hemostats provide a matrix as a scaffold for the body's natural clotting mechanism. Topical Hemostats come in different forms, including powders, sprays, and gels, and can be applied directly to the bleeding site. One of the primary benefits of topical Hemostats is their ability to reach and stop bleeding in challenging-to-reach or awkward spaces that Hemostatic clips cannot reach.

Using Hemostats is essential in achieving successful minimally invasive surgeries. Hemostats help surgeons achieve quick hemostasis, reduce the risk of bleeding complications, and allow for a more efficient surgical procedure. With the growing demand for minimally invasive surgeries in the healthcare industry, using Hemostats is becoming more crucial than ever. As new technologies emerge in the surgical industry, developments and innovations in Hemostats will continue to advance, leading to better patient outcomes.

Frequently Asked Questions
  1. How big is the Hemostats Market?
    Ans. The Global Hemostats Market size was estimated at USD 3.23 billion in 2023 and expected to reach USD 3.42 billion in 2024.
  2. What is the Hemostats Market growth?
    Ans. The Global Hemostats Market to grow USD 4.75 billion by 2030, at a CAGR of 5.65%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.